Regulation - Depomed


Current filters:


Popular Filters

US FDA grants priority review for Mallinckrodt's pain relief drug


The US Food and Drug Administration has accepted and granted a priority review for the New Drug Application…

DepomedMallinckrodtNorth AmericaOxycodone and AcetaminophenPharmaceuticalRegulation

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?


US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

FDA should not approve paroxetine or gabapentin for hot flashes, says Public Citizen


A drug approved to treat depression and other mental health disorders and another designed to prevent…

DepomedgabapentinHisamitsu PharmaNorth AmericaparoxetinePharmaceuticalRegulationWomen's Health

Back to top